On this page
The editorial assessment
The product card is not the entire clinical invoice. What is the appointment charge, and does the proposed supply carry any additional monitoring or pharmacy fee?
- Published payment basis
- $145 advertised 30-day BPC-157 product supply
- Preparation record
- Exact prescribed route and quantity need confirmation
- Care process
- Consultations and monitoring stated separately from product prices
- Access setting
- New York clinic consultation
What is documented
- Consultations and monitoring stated separately from product prices
- The product card is not the entire clinical invoice
What needs an answer
- Its treatment menu separates the advertised product charge from consultation and monitoring.
- What is the appointment charge, and does the proposed supply carry any additional monitoring or pharmacy fee?
A thirty-day supply is not thirty days of complete care
Genesis's $145 entry is unusually specific about its period but incomplete as a total: consultations and monitoring are described separately. Without the prescribed route and quantity, even the product component cannot be matched confidently to an injectable-vial package elsewhere. Keep the product entry separate from clinical charges in the cost planner.
The unresolved term
What is the appointment charge, and does the proposed supply carry any additional monitoring or pharmacy fee?
A contrasting service record
The Better Med Spa service review documents another purchasing structure: the page contains two different two-month figures, so a single unqualified longer-plan price would hide a real inconsistency. That distinction changes which components belong in a like-for-like comparison.
On the record
The documents supporting this report.
- Genesis Health NYC official BPC-157 service or pricing recordCompany website